Having trouble accessing articles? Reset your cache.

ITI-007: Phase Ib/II data

A double-blind, placebo-controlled, multiple-ascending dose Phase Ib/II trial in 45 patients showed

Read the full 126 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE